Adare Pharma Solutions

Adare Pharma Solutions is excited to announce a collaboration with OnDosis® AB to support the advancement of its lead U.S. ADHD program. Combining Adare's expertise in oral solid dose development and manufacturing with the OnDosis® Dosage Manager platform, which enables individualized dosing of oral medicines, the collaboration supports a more personalized approach to treatment and the program's progression toward the U.S. market. Together, we're working to expand the possibilities of precision dosing for patients. Read more ➡️ https://lnkd.in/eJ2biYfT

At Adare, we transform challenging molecules into intuitive, patient-centered therapies that improve adherence, clinical success, and quality of life. Your Molecule. Engineered for the Patient. Optimized for the Market. Connect with Adare at CPHI Milan, 𝗦𝘁𝗮𝗻𝗱 𝟲𝗙𝟭𝟴 to discover our end-to-end CDMO solutions. Schedule a meeting at the show ➡️ https://lnkd.in/eCw7WnY2/?utm_campaign=CPHI2026&utm_source=linkedin&utm_medium=paid&utm_id=1211857404&hsa_acc=513175105&hsa_cam=1211857404&hsa_grp=899375784&hsa_ad=1564115104&hsa_net=linkedin&hsa_ver=3

At Adare, we transform challenging molecules into intuitive, patient-centered therapies that improve adherence, clinical success, and quality of life. Your Molecule. Engineered for the Patient. Optimized for the Market. Connect with Adare at CPHI Milan, 𝗦𝘁𝗮𝗻𝗱 𝟲𝗙𝟭𝟴 to discover our end-to-end CDMO solutions.

When swallowing difficulties and hand tremors make traditional capsules challenging to administer, patient friendly drug delivery options can make a meaningful difference. Explore how Adare Pharma Solutions developed a convenient sprinkle formulation to support easier medication administration. Read the full case study to learn more. ➡️ https://lnkd.in/epAvNxby//?utm_source=linkedin&utm_medium=paid&utm_id=1201981184&utm_campaign=2026_SprinkleFormulation&hsa_acc=513175105&hsa_cam=1201981184&hsa_grp=882410814&hsa_ad=1508751794&hsa_net=linkedin&hsa_ver=3 #CDMO #Pharma

3D printing is redefining what is possible in pharmaceuticals by making true personalization in medicine more achievable and enabling new approaches to drug delivery. This shift is helping move healthcare toward more precise, adaptable solutions designed around individual patient needs. On Wednesday, July 22 at 10:00am ET, join Adare’s Giuseppe De Franza for a discussion on the latest developments in pharmaceutical 3D printing. The session will highlight key breakthroughs, important regulatory considerations, and the opportunities this technology is creating for the future of patient care. Register now ➡️ https://lnkd.in/eDrArJ3u in partnership with Contract Pharma #OralSolidDose #PharmaWebinar #CDMO #PharmaInnovation #PharmaManufacturing

Looking to differentiate your oral drug product? 3D screen printing enables complex dosage forms, tailored release profiles, and faster innovation. Explore what 3D screen printing could unlock for your next oral drug product. Learn more ➡️ https://lnkd.in/efg9qJSw